Nasdaq-EEX Deal Hits Snag: Reportedly Risks Full-Scale Investigation By EU Antitrust Regulators
EU may investigate Nasdaq and EEX deal unless Deutsche Boerse improves competition measures. Nasdaq Power acquisition aims to serve Nordics.
Why Coherent Shares Are Seeing Blue Skies Today
Jim Anderson appointed CEO of Coherent Corp. succeeding retiring CEO Dr. Mattera. Coherent recently launched new laser sensor.
VIX Spikes 8% As Stocks Sink; Bonds, Gold Rise On Growth Concerns; Meme Stocks Roar, Peso Plummets: What’s Driving Markets Monday?
All major U.S. equity indices opened the week with losses, as traders shifted to safe-haven bonds and gold amid concerns affecting the health of the U.S. manufacturing activity.
What’s Going On With Chinese EV Stocks Nio, XPeng, Li Auto Monday?
Chinese EV stocks NIO, XPEV, and LI saw strong May delivery numbers, with NIO reporting a 234% increase in sales. Discounts and potential tariffs impact profits.
Why Is Telephone And Data Systems Stock Surging Today?
TDS announced definitive deal to sell OneNeck IT Solutions and Data Center Holdings to US Signal. Expected to close in Q3 2024, provides additional capital for TDS Telecom's fiber program.
Nucor Expands Beyond Steelmaking With Acquisition Of Rytec: Details
Nucor to acquire Rytec Corporation for $565 million, expanding its product portfolio and downstream businesses.
BD Bolsters Portfolio With $4.2B Cash Deal For Edwards Lifesciences’ Critical Care Group: Details
BD (Becton, Dickinson and Company) will acquire Edwards Lifesciences' Critical Care product group for $4.2 billion in cash. This acquisition enhances BD's portfolio with advanced AI-enabled monitoring technologies, aiming to improve patient outcomes in critical care settings. The transaction is expected to boost BD's financial performance, delivering immediate accretive benefits and long-term revenue growth.
Treasury Yields Fall, Dollar Weakens As Manufacturing Activity Gauge Contracts More Than Expected
Yields on the benchmark 10-year Treasury bond fell by nine basis points to 4.41%, marking the third straight day of declines.
Blackstone Weighs Sale Of Japanese Pharma Firm Alinamin: Report
Blackstone reportedly considers sale of Japanese consumer healthcare firm Alinamin Pharmaceutical (previously owned by Takeda) for $1.9B, attracting interest from other firms.
Why Lattice Semiconductor Shares Are Diving Premarket Today
Lattice appointed Esam Elashmawi, chief marketing and strategy officer, as Interim Chief Executive Officer, effective immediately.